YIFAN PHARMACEUTICAL CO (SZSE:002019) 3-Year Book Growth Rate : -0.40% (As of Mar. 2024)

View and export this data going back to 2004. Start your Free Trial

What is YIFAN PHARMACEUTICAL CO 3-Year Book Growth Rate?

YIFAN PHARMACEUTICAL CO's Book Value per Share for the quarter that ended in Mar. 2024 was ¥6.86.

During the past 12 months, YIFAN PHARMACEUTICAL CO's average Book Value per Share Growth Rate was -5.10% per year. During the past 3 years, the average Book Value per Share Growth Rate was -0.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was 4.60% per year. During the past 10 years, the average Book Value per Share Growth Rate was 20.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of YIFAN PHARMACEUTICAL CO was 66.00% per year. The lowest was -19.20% per year. And the median was 26.00% per year.

Competitive Comparison of YIFAN PHARMACEUTICAL CO's 3-Year Book Growth Rate

For the Drug Manufacturers - General subindustry, YIFAN PHARMACEUTICAL CO's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

YIFAN PHARMACEUTICAL CO's 3-Year Book Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, YIFAN PHARMACEUTICAL CO's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where YIFAN PHARMACEUTICAL CO's 3-Year Book Growth Rate falls into.

YIFAN PHARMACEUTICAL CO 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

YIFAN PHARMACEUTICAL CO (SZSE:002019) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

YIFAN PHARMACEUTICAL CO 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of YIFAN PHARMACEUTICAL CO's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » YIFAN PHARMACEUTICAL CO LTD (SZSE:002019) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300

Website

https://en.yifanyy.com

YIFAN PHARMACEUTICAL CO LTD is a China-based company engaged in pharmaceutical innovation and manufacturing. The company focuses its activities on key areas like macromolecular biologics, high-value pharmaceuticals, and differentiated traditional Chinese medicines. The products of the company are F-627 for Neutropenia and Parkinson's disease, F-652 for acute alcoholic hepatitis, GvHD and acute pancreatitis and F-899 for growth deficiency. The company's products are sold in China and internationally.

YIFAN PHARMACEUTICAL CO (SZSE:002019) Headlines

No Headlines